Interestingly, when we treated AML cells with JNK inhibitor SP600125 (10uM) at the same time as the DNR treatment, it was found that SP600125 was able to reduce the cell apoptosis rate in each group. The gene discussed is MAPK8; the disease is acute myeloid leukemia.